Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis

E. Radzikowska (Warsaw, Poland), E. Wiatr (Warsaw, Poland), K. Blasinska-Przerwa (Warsaw, Poland), M. Jeskiewicz (Warsaw, Poland), R. Langfort (Warsaw, Poland), B. Maksymiuk (Warsaw, Poland), K. Modrzewska (Warsaw, Poland), I. Bestry (Warsaw, Poland), M. Zaleska (Warsaw, Poland), J. Szopinski (Warsaw, Poland), A. Jerzemska (Bydgoszcz, Poland), M. Ochman (Zabrze, Poland), W. Naumnik (Bialystok, Poland), D. Jastrzebski (Zabrze, Poland), W. Piotrowski (Lódz, Poland), K. Roszkowski-Sliz (Warsaw, Poland)

Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Radzikowska (Warsaw, Poland), E. Wiatr (Warsaw, Poland), K. Blasinska-Przerwa (Warsaw, Poland), M. Jeskiewicz (Warsaw, Poland), R. Langfort (Warsaw, Poland), B. Maksymiuk (Warsaw, Poland), K. Modrzewska (Warsaw, Poland), I. Bestry (Warsaw, Poland), M. Zaleska (Warsaw, Poland), J. Szopinski (Warsaw, Poland), A. Jerzemska (Bydgoszcz, Poland), M. Ochman (Zabrze, Poland), W. Naumnik (Bialystok, Poland), D. Jastrzebski (Zabrze, Poland), W. Piotrowski (Lódz, Poland), K. Roszkowski-Sliz (Warsaw, Poland). Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis. 3683

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: